Publicaciones en colaboración con investigadores/as de Centro Medico Teknon (15)

2023

  1. Experience With a Non-Hormonal Centella Asiatica, Hyaluronic Acid and Prebiotic-Based Vaginal Gel in Women With Recurrent Vulvovaginal Candidiasis: Case Studies

    Clinical Medicine Insights: Case Reports, Vol. 16

2020

  1. Enhancing global access to cancer medicines

    CA Cancer Journal for Clinicians, Vol. 70, Núm. 2, pp. 105-124

  2. Molecular features of metaplastic breast carcinoma: An infrequent subtype of triple negative breast carcinoma

    Cancers, Vol. 12, Núm. 7, pp. 1-13

2019

  1. The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin

    Frontiers in Oncology, Vol. 9, Núm. MAR

2018

  1. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study

    Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704

  2. Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

    The Lancet Oncology, Vol. 19, Núm. 6, pp. 812-824

  3. Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy

    Melanoma Research, Vol. 28, Núm. 3, pp. 195-203

  4. Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

    Annals of Oncology, Vol. 29, Núm. 4, pp. 881-887

  5. Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis

    Clinical Breast Cancer, Vol. 18, Núm. 5, pp. e919-e926

2017

  1. The effects of allogenic stem cells in a murine model of hind limb diabetic ischemic tissue

    PeerJ, Vol. 2017, Núm. 8

  2. The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies

    Cancer Treatment Reviews, Vol. 61, pp. 53-60

2015

  1. The expanding role of pertuzumab in the treatment of HER2-positive breast cancer

    Breast Cancer: Targets and Therapy, Vol. 7, pp. 125-132

2014

  1. Changes in breast cancer reports after pathology second opinion

    Breast Journal

2013

  1. Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance

    Journal of the American College of Cardiology, Vol. 62, Núm. 17, pp. 1621-1631

2007

  1. Investigación neonatal en España

    Anales de Pediatria